- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 200
Zhongneng United brings together investors for $167m
Huayun Financial Leasing has taken part in a $145m funding round for Zhongneng United, while Five Star supplied $21.8m in series B-plus capital.
Jul 31, 2019PredictImmune foresees series B
PredictImmune, a Cambridge spinout, added series B capital from investors including Cambridge Enterprise and CIC to $6.1m in series A funding raised last April.
Jul 30, 2019Corporates go through RedDoorz in $45m series B
MCN Group joined existing investor SIG in the hotel booking platform's series B round, which was co-led by Qiming Venture Partners and Jungle Ventures.
Jul 30, 2019Sense recharges series B to reach $30m
Schneider Electric has been joined by Landis+Gyr, MKB and IDO Investments for a $10m series B extension that boosted the home energy monitoring platform's total funding to $50m.
Jul 30, 2019Linkfin inks $50m series B
The big data and AI-powered automotive financing platform has secured funding in a round co-led by JD Digits and Tencent, which took part alongside Bertelsmann Asia Investments.
Jul 29, 2019YY looks to play in Sandbox Network
The iDreamSky-backed online game development platform has raised $14.5m in a series B round that included strategic investor YY.
Jul 29, 2019Balena calls in GE for series B
The Soracom and Ericsson-backed software development and management technology provider has raised $14.4m in a round that included General Electric unit GE Ventures.
Jul 29, 2019Corporate venturing deal net: 22-26 July 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Jul 26, 2019TScan takes in $48m
Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.
Jul 26, 2019TScan takes in $48m
The Alphabet and Novartis-backed T cell cancer therapy developer has secured series B capital that took its overall funding to $48m.
Jul 26, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


